WordNet

a solution obtained by steeping or soaking a substance (usually in water) (同)extract
the process of extracting certain active properties (as a drug from a plant) by steeping or soaking (usually in water)
(medicine) the passive introduction of a substance (a fluid or drug or electrolyte) into a vein or between tissues (as by gravitational force)
the act of infusing or introducing a certain modifying element or quality; "the teams continued success is attributable to a steady infusion of new talent"
person who makes a gift of property (同)giver, presenter, bestower, conferrer
(medicine) someone who gives blood or tissue or an organ to be used in another person (the host)
the head of an organized crime family (同)father
an agranulocytic leukocyte that normally makes up a quarter of the white blood cell count but increases in the presence of infection (同)lymph cell

PrepTutorEJDIC

〈U〉(…を…に)教え込むこと,(…の)鼓吹,注入《+『of』+『名』+『into』+『名』》 / 〈C〉水(湯)に浸してできたもの;振り出し汁
寄付者,寄贈者 / (移植用の組織・器官の)提供者,献血者
《Don》ドン(Sirに当たるスペイン語で男性の洗礼名の前につける) / 〈C〉スペイン貴族(紳士) / 〈C〉(オックスフォード・ケンブリッジ両大学の)学監,指導教授 / 〈C〉《英》大学教師
〈衣服〉‘を'着る,〈帽子〉‘を'かぶる[do onの短縮形]

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 同種造血幹細胞移植後に血液癌の再発を予防および治療するための免疫療法 immunotherapy for the prevention and treatment of relapse following allogeneic hematopoietic cell transplantation
2. 再発性または難治性の急性骨髄性白血病の治療 treatment of relapsed or refractory acute myeloid leukemia
3. 造血細胞移植後の移植片対腫瘍効果の生物学 biology of the graft versus tumor effect following hematopoietic cell transplantation
4. 骨髄異形成症候群における造血細胞移植 hematopoietic cell transplantation in myelodysplastic syndromes
5. 慢性骨髄性白血病における造血細胞移植 hematopoietic cell transplantation in chronic myeloid leukemia

Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions.

Jaiswal SR1, Zaman S2, Chakrabarti A3, Sen S4, Mukherjee S4, Bhargava S2, Ray K5, O'Donnell PV6, Chakrabarti S7.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant.2016 Oct;22(10):1867-73. doi: 10.1016/j.bbmt.2016.07.016. Epub 2016 Jul 25.
We carried out post-transplantation cyclophosphamide (PTCy)-based haploidentical peripheral blood stem cell transplantation in 51 patients with refractory/relapsed acute myeloid leukemia not in remission. The first 10 patients received nonmyeloablative conditioning followed by planned granulocyte co
PMID 27470289

Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.

Teltschik HM1, Heinzelmann F2, Gruhn B3, Feuchtinger T4, Schlegel P1, Schumm M1, Kremens B5, Müller I6, Ebinger M1, Schwarze CP1, Ottinger H7, Zips D2, Handgretinger R1, Lang P8.
British journal of haematology.Br J Haematol.2016 Oct;175(1):115-22. doi: 10.1111/bjh.14190. Epub 2016 Jun 24.
Graft failure is a life-threatening complication after allogeneic haematopoietic stem cell transplantation (HSCT). We report a cohort of 19 consecutive patients (median age: 8·5 years) with acute leukaemias (n = 14) and non-malignant diseases (n = 5) who experienced graft failure after previou
PMID 27341180

Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.

Berens C1, Heine A2, Müller J1, Held SA2, Mayer K2, Brossart P2, Oldenburg J1, Pötzsch B1, Wolf D2, Rühl H3.
Cytotherapy.Cytotherapy.2016 Oct;18(10):1325-31. doi: 10.1016/j.jcyt.2016.06.014. Epub 2016 Aug 1.
BACKGROUND AIMS: Leukapheresis products for hematopoietic stem cell transplantation can be cryopreserved for various indications. Although it is known that CD34(+) cells tolerate cryopreservation well, a significant loss of CD3(+) cells has been observed, which has been ascribed to several factors,
PMID 27491794

Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years

WADA Akinori,KOBAYASHI Naoki,ASANUMA Shinsuke,MATSUOKA Satomi,KOSUGI Mizuha,FUJII Shiro,NOGUCHI Shinsuke,MIYAZONO Takayoshi,NAKATA Masanobu,OTA Shuichi,IMAI Kiyotoshi,HIRANO Teiichi,OGASAWARA Masahiro,KIYAMA Yoshio,KASAI Masaharu
International journal of hematology 93(1), 118-122, 2011-01-01
NAID 10029532775

緒方正男,今村朋之,池脇淳二,大塚英一,立川良明,宮子博,菊池博,門田淳一,犀川哲典
日本輸血細胞治療学会誌 = Japanese journal of transfusion and cell therapy 55(6), 705-710, 2009-12-25
… 敗血症性ショックを来した．骨髄検査では著明な細胞融解像と顆粒球系細胞の消失が認められ，キメリズム解析ではホスト由来CD3陽性細胞を48.3%認めた．Full chimerismへの転換を目的にDonor lymphocyte infusions（DLI）（CD3陽性細胞1×107/kg）を行った．DLI後full chimerismへの到達に一致して好中球は速やかに回復し，敗血症症状も改善した．しかし同時に間質性肺炎を来たしday 92に死亡した． …
NAID 10026334341

Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions

YOSHIMITSU Makoto,FUJIWARA Hiroshi,OZAKI Atsuo,HAMADA Heiichiro,MATSUSHITA Kakushi,ARIMA Naomichi,TEI Chuwa
International journal of hematology 88(3), 331-335, 2008-10-15
NAID 10023970479